Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma-Reference-Cited by-同舟云学术

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma

Published:2015-12-28 Issue:5 Volume:76 Page:479-490
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kibel Adam S.¹,Ahn Jiyoung²,Isikbay Masis¹,Klim Aleksandra³,Wu William S.³,Hayes Richard B.²,Isaacs William B.⁴,Daw E. Warwick⁵

Affiliation:

1. Division of Urology, Brigham and Women's Hospital; Harvard Medical School; Boston Massachusetts

2. Division of Epidemiology, Department of Environmental Medicine; NYU School of Medicine; New York New York

3. Division of Urologic Surgery; Washington University School of Medicine; St. Louis Missouri

4. Department of Urology; Johns Hopkins Medical Institutions; Baltimore Maryland

5. Departments of Genetics; Washington University School of Medicine; St. Louis Missouri

Funder

National Cancer Institute

The St. Louis Men's Group Against Cancer

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23139/fullpdf

Reference84 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context;Draisma;J Natl Cancer Inst,2009

3. Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends;Etzioni;J Natl Cancer Inst,2002

4. Absolute effect of prostate cancer screening: Balance of benefits and harms by center within the European randomized study of prostate cancer screening;Auvinen;Clin Cancer Res,2015

5. Active surveillance for early-stage prostate cancer: Review of the current literature;Dall'Era;Cancer,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer;Current Pharmaceutical Biotechnology;2024-11

2. CDK5: an oncogene or an anti-oncogene: location location location;Molecular Cancer;2023-11-23

3. Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review;JCO Oncology Practice;2023-05

4. The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective;Frontiers in Molecular Medicine;2023-02-28

5. Prediction of chemoresistance trait of cancer cell lines using machine learning algorithms and systems biology analysis;Journal of Big Data;2021-07-05